These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3069943

  • 1. Antitumor activity of cisplatin analogs against malignant ovarian tumor xenografts into nude mice.
    Hamaguchi K, Miyahara K, Nishimura H, Tashiro M, Kishi N, Matsumura T, Yakushiji M, Kato T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1755-9. PubMed ID: 3069943
    [Abstract] [Full Text] [Related]

  • 2. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
    Sawada M, Ozaki M, Hongo J, Hirota Y, Inagaki M, Taniguchi H, Tateishi R, Mori Y.
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):693-8. PubMed ID: 3548596
    [Abstract] [Full Text] [Related]

  • 3. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
    Boven E, van der Vijgh WJ, Nauta MM, Schlüper HM, Pinedo HM.
    Cancer Res; 1985 Jan; 45(1):86-90. PubMed ID: 4038381
    [Abstract] [Full Text] [Related]

  • 4. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y, Imai S, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Tobe T.
    Anticancer Res; 1991 Nov; 11(2):761-7. PubMed ID: 2064331
    [Abstract] [Full Text] [Related]

  • 6. In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas.
    Rose WC, Basler GA.
    In Vivo; 1990 Nov; 4(6):391-6. PubMed ID: 2103379
    [Abstract] [Full Text] [Related]

  • 7. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR.
    Cancer Res; 1993 Jun 01; 53(11):2581-6. PubMed ID: 8388318
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C, Bettio F, Baccichetti F, Trevisan A, Giovagnini L, Fregona D.
    Chem Biol Interact; 2004 Jun 30; 148(1-2):37-48. PubMed ID: 15223355
    [Abstract] [Full Text] [Related]

  • 9. Preclinical antitumor activity of the oral platinum analog satraplatin.
    Wosikowski K, Lamphere L, Unteregger G, Jung V, Kaplan F, Xu JP, Rattel B, Caligiuri M.
    Cancer Chemother Pharmacol; 2007 Sep 30; 60(4):589-600. PubMed ID: 17541592
    [Abstract] [Full Text] [Related]

  • 10. [Preclinical evaluation of several cisplatinum analogs against human esophageal carcinoma by subrenal capsule assay].
    Terashima M, Ikeda K, Kawamura S, Takagane A, Maesawa C, Sudoh T, Okamoto K, Ishida K, Satoh M, Saito K.
    Gan To Kagaku Ryoho; 1990 Feb 30; 17(2):269-73. PubMed ID: 2405778
    [Abstract] [Full Text] [Related]

  • 11. [Comparative studies of the antitumor activities of CDDP and the analogs--using gynecological carcinomas transplanted into nude mice].
    Suzumori K, Yasui Y, Suzumori K, Yagami Y.
    Gan To Kagaku Ryoho; 1989 Mar 30; 16(3 Pt 1):387-91. PubMed ID: 2649007
    [Abstract] [Full Text] [Related]

  • 12. [Effect of a newly developed platinum compound cis-1, 1-cyclobutane dicarboxylato-(2R)-2-methyl-1,4-butane diamine platinum (II), on human ovarian tumors transplanted into nude mice].
    Sawada M, Ozaki M, Taniguchi H, Tateishi R, Mori Y, Mino K.
    Gan To Kagaku Ryoho; 1988 Apr 30; 15(4 Pt 1):637-41. PubMed ID: 3355185
    [Abstract] [Full Text] [Related]

  • 13. [Antitumor effect of JM-8 (a cisplatin analogue) on testicular cancer cells in vitro and in vivo].
    Hashimura T, Okada K, Yoshida O.
    Gan To Kagaku Ryoho; 1985 May 30; 12(5):1137-42. PubMed ID: 3888118
    [Abstract] [Full Text] [Related]

  • 14. [The prospect for cisplatin analogs from the experimental standpoint].
    Tashiro T.
    Gan To Kagaku Ryoho; 1989 Apr 30; 16(4 Pt 2-2):1358-65. PubMed ID: 2543305
    [Abstract] [Full Text] [Related]

  • 15. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
    Goddard P, Valenti M, Kelland LR.
    Anticancer Res; 1994 Apr 30; 14(3A):1065-70. PubMed ID: 8074451
    [Abstract] [Full Text] [Related]

  • 16. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
    Taetle R, Rosen F, Abramson I, Venditti J, Howell S.
    Cancer Treat Rep; 1987 Mar 30; 71(3):297-304. PubMed ID: 3815395
    [Abstract] [Full Text] [Related]

  • 17. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
    Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1996 Mar 30; 16(1):251-6. PubMed ID: 8615617
    [Abstract] [Full Text] [Related]

  • 18. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
    Manetta A, Gamboa G, Nasseri A, Podnos YD, Emma D, Dorion G, Rawlings L, Carpenter PM, Bustamante A, Patel J, Rideout D.
    Gynecol Oncol; 1996 Feb 30; 60(2):203-12. PubMed ID: 8631539
    [Abstract] [Full Text] [Related]

  • 19. [Antitumor activity and toxicity of KB-5424 R, a newly developed antitumor platinum compound].
    Yamaguchi H, Kubota T, Takahara T, Takeuchi T, Furukawa T, Kase S, Josui K, Kodaira S, Ishibiki K, Abe O.
    Gan To Kagaku Ryoho; 1991 Jun 30; 18(7):1135-41. PubMed ID: 2053772
    [Abstract] [Full Text] [Related]

  • 20. Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo.
    Saikawa Y, Kubota T, Kuo TH, Tanino H, Kase S, Furukawa T, Watanabe M, Ishibiki K, Kitajima M, Hoffman RM.
    Anticancer Res; 1994 Jun 30; 14(2A):461-4. PubMed ID: 8017848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.